India Coronavirus Diagnostics Market to grow with a CAGR of 3.68% through forecast period
Increasing healthcare infrastructure and a supportive
regulatory environment are the major drivers for the India Coronavirus
Diagnostics Market in the forecast period, 2026-2030
According to TechSci Research report, “India
Coronavirus Diagnostics Market - By Region, Competition,
Opportunities and Forecast, 2030F”, India Coronavirus
Diagnostics Market was valued at USD 2.11 Billion in 2024 and is expected to
reach by USD 2.61 Billion by 2030, growing at a CAGR of 3.68% through
2030. This can be due to collaborations
and partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market. The emergence of new variants of the SARS-CoV-2 virus drove the demand
for Coronavirus diagnostics. New variants often came with changes in their
genetic makeup, which could impact their transmissibility, virulence, and
ability to evade immunity. To track the spread and impact of these variants, it
was essential to conduct genomic surveillance and diagnostic testing. This
drove the need for diagnostic tests capable of detecting specific variants.
Variants could affect the effectiveness of vaccines. To assess the efficacy of
existing vaccines against new variants and to detect breakthrough infections,
diagnostic tests were crucial. This may have led to a demand for tests that
could identify specific mutations associated with these variants. Some variants
exhibited altered patterns of transmission or severity of disease. Identifying
and understanding these variants through diagnostic testing helped health
authorities implement targeted interventions in regions where specific variants
were prevalent. Detecting and monitoring variants was important for contact
tracing efforts. It helped in understanding the transmission dynamics and
identifying clusters of cases associated with variants.
Browse over XX market data Figures
and spread through XX Pages and an in-depth
TOC on " India Coronavirus Diagnostics
Market”
India Coronavirus Diagnostics Market is segmented
based on type of test, user, full test time, end-user, and by region.
Based on end-user, in 2024, the India Coronavirus
Diagnostics Market largest share was held by Public Health Labs segment in the
forecast period and is predicted to continue expanding over the coming
years. Public Health Labs, often operated
by government health authorities, played a central role in the country's
response to the COVID-19 pandemic. Governments at various levels, including
national, state, and local authorities, relied heavily on these labs for
conducting large-scale testing, contact tracing, and surveillance efforts.
Public Health Labs typically have the infrastructure and resources to handle a
large volume of diagnostic tests. They often have the equipment, trained
personnel, and regulatory clearances required for diagnostic testing, which
made them crucial in scaling up testing capacity. The Indian government, in
coordination with public health authorities, devised a national testing
strategy to manage the pandemic. This strategy often involved an extensive
network of Public Health Labs that followed standardized testing protocols.
Public Health Labs had an advantage in obtaining regulatory approvals and
certifications to conduct COVID-19 testing. They were often among the first to
receive approvals for new diagnostic methods and technologies. Public Health Labs
were responsible for collecting data on the spread of the virus, monitoring
trends, and identifying hot spots. This data was essential for policymakers in
making informed decisions.
Based on region, South India is the
fastest-growing region in India’s coronavirus diagnostics market due to several
key factors that support rapid development and adoption of diagnostic
solutions. The region has a relatively strong healthcare infrastructure with a
dense network of hospitals, laboratories, and research institutions that enable
faster testing and diagnosis. Cities like Bengaluru, Chennai, and Hyderabad
serve as hubs for biotechnology and medical innovation, which has contributed
to the early adoption of advanced diagnostic technologies such as RT-PCR and
rapid antigen testing. The population in South India is generally more
health-conscious and has a higher literacy rate, which has led to increased
awareness about the importance of testing and early detection. This awareness
has driven higher testing rates and demand for reliable diagnostic services.
Additionally, state governments in the region have been proactive in launching
public health campaigns, setting up mobile testing units, and collaborating
with private diagnostic firms to expand access to testing, especially during peak
infection periods.
The presence of manufacturing facilities for
diagnostic kits and reagents in the region has helped ensure a steady supply of
testing materials, reducing delays and bottlenecks. These combined factors have
positioned South India as a leader in scaling and modernizing COVID-19
diagnostics, contributing to its rapid market growth.
Some of the major companies
operating in the India Coronavirus Diagnostics Market include:
·
Abbott Laboratories India Ltd.,
·
Biomerieux India Private Limited
·
Bio-Rad Laboratories India Pvt.
Ltd.
·
DHR Holding India Pvt Ltd.
·
Roche Diagnostics India Pvt. Ltd
·
Pfizer India Ltd.
·
Mylab Discovery Solutions Pvt. Ltd.
·
Thermo Fisher Scientific India Pvt.
Ltd.
·
CPC Diagnostics Pvt. Ltd.
·
Zydus Cadila Ltd.
Download Free Sample Report
Customers can also request 10% free
customization on this report.
“The India Coronavirus Diagnostics Market experienced
significant growth due to increased testing demand, rising public awareness,
and the emergence of new virus variants. Government initiatives, including
widespread testing campaigns and public-private partnerships, played a vital
role in expanding diagnostic capabilities. Technological advancements such as
RT-PCR, rapid antigen, and home-based testing kits further boosted market
expansion. The need for early detection, surveillance, and genomic sequencing contributed
to sustained demand. Urban centers and high-risk populations drove much of the
testing volume, while rural outreach improved accessibility. Overall, the
market evolved rapidly, adapting to the changing dynamics of the pandemic and
public health priorities" said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.
"India Coronavirus Diagnostics Market By Type of Test (Molecular, Serology), By User (Single, Multiple), By Full Test Time (Less Than 60 Minutes, 1 Hours to 12 Hours, 13 Hours-24Hours, More Than 1 Day), By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others), By Region, Competition, Opportunities and Forecast, 2020-2030", has evaluated
the future growth potential of India Coronavirus Diagnostics Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide innovative market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India Coronavirus Diagnostics Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com